Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis-Reference-Cited by-同舟云学术

Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis

Published:2017-05 Issue:3 Volume:16 Page:358-366
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Nichols Dave P.,Happoldt Carrie L.,Bratcher Preston E.,Caceres Silvia M.,Chmiel James F.,Malcolm Kenneth C.,Saavedra Milene T.,Saiman Lisa,Taylor-Cousar Jennifer L.,Nick Jerry A.

Funder

Gilead Sciences (DPN)

National Institutes of Health/National Heart Lung & Blood Institute

Cystic Fibrosis Foundation Therapeutics NICHOL15

Cystic Fibrosis Foundation

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference49 articles.

1. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health;Mogayzel;Am J Respir Crit Care Med,2013

2. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic fibrosis inhaled tobramycin study group;B.W. Ramsey, M.S. Pepe;N Engl J Med,1999

3. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial;Saiman;JAMA,2003

4. Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products;Caceres;Antimicrob Agents Chemother,2014

5. Effects of azithromycin in Pseudomonas aeruginosa burn wound infection;Nichols;J Surg Res,2013

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergence of Tobramycin Escherichia coli resistance in poultry meat linked to biocides overuse during COVID-19;Revista Científica de la Facultad de Ciencias Veterinarias;2023-02-07

2. Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance;Clinical Microbiology and Infection;2022-12

3. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis;Cochrane Database of Systematic Reviews;2022-11-14

4. Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance;2022-02-28

5. Bronchiectasis and inhaled tobramycin: A literature review;Respiratory Medicine;2022-02